| scholarly article | Q13442814 |
| P50 | author | Edward A. Dennis | Q54261384 |
| P2093 | author name string | Oswald Quehenberger | |
| P2860 | cites work | Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients | Q77555242 |
| Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer | Q82371949 | ||
| Listening to the ocean's heartbeat | Q82678124 | ||
| Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis | Q82780696 | ||
| Increased choline kinase activity and elevated phosphocholine levels in human colon cancer | Q22009964 | ||
| Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters | Q24290568 | ||
| Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1 | Q24314828 | ||
| Biological, clinical and population relevance of 95 loci for blood lipids | Q24622541 | ||
| GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects | Q24630455 | ||
| Lipidomics reveals a remarkable diversity of lipids in human plasma | Q24633282 | ||
| Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism | Q24650184 | ||
| Update of the LIPID MAPS comprehensive classification system for lipids | Q24652954 | ||
| HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
| Monogenic hypercholesterolemia: new insights in pathogenesis and treatment | Q24672834 | ||
| Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border | Q25257385 | ||
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. | Q27863762 | ||
| Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial | Q28143204 | ||
| The emerging role of lysophosphatidic acid in cancer | Q28191543 | ||
| Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease | Q28215274 | ||
| Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase | Q28217851 | ||
| Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes | Q28264518 | ||
| Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry | Q61863022 | ||
| Obesity among adults in the United States--no statistically significant change since 2003-2004 | Q64127774 | ||
| Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats | Q70539192 | ||
| Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy | Q71322713 | ||
| Differential oxidation of individual dietary fatty acids in humans | Q73019068 | ||
| Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers | Q77204834 | ||
| A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis | Q28270998 | ||
| Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis | Q28271008 | ||
| Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer | Q28362929 | ||
| Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients | Q28475747 | ||
| Evolution of mammals and their gut microbes | Q28755326 | ||
| THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM | Q29391553 | ||
| Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease | Q29619334 | ||
| Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 | Q29619644 | ||
| Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis | Q30433021 | ||
| Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study | Q30829796 | ||
| Studies of human tumors by MRS: a review | Q30833628 | ||
| Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy | Q30906322 | ||
| Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. | Q33498603 | ||
| Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans | Q33602334 | ||
| Blood-based biomarkers of microvascular pathology in Alzheimer's disease | Q33625663 | ||
| Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells | Q33699139 | ||
| Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids | Q33799614 | ||
| Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy | Q33809226 | ||
| Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo | Q33864159 | ||
| A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas | Q34012467 | ||
| Blood sphingolipidomics in healthy humans: impact of sample collection methodology | Q34116310 | ||
| Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy | Q34135239 | ||
| Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells | Q34260479 | ||
| Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes | Q34308065 | ||
| A mouse macrophage lipidome | Q34400967 | ||
| Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). | Q34464251 | ||
| Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer | Q34517736 | ||
| Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells | Q34544900 | ||
| The phospholipase A2 superfamily and its group numbering system | Q34566140 | ||
| Dietary patterns and risk of dementia: the Three-City cohort study. | Q34584817 | ||
| Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Q34624835 | ||
| Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations | Q34637050 | ||
| Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study | Q34667064 | ||
| Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters | Q34698702 | ||
| Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology | Q34952213 | ||
| Metabolome in schizophrenia and other psychotic disorders: a general population-based study | Q34971495 | ||
| Magnetic Resonance Spectroscopy of cancer-practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma | Q34974985 | ||
| Non-alcoholic fatty liver disease: an overview | Q35009628 | ||
| Choline phospholipid metabolism: a target in cancer cells? | Q35549481 | ||
| The ins and outs of lysophosphatidic acid signaling. | Q35845615 | ||
| Dietary fat, insulin sensitivity and the metabolic syndrome. | Q35857212 | ||
| Applications of mass spectrometry to lipids and membranes | Q36135725 | ||
| Metabolic syndrome: focus on dyslipidemia | Q36461906 | ||
| Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver | Q36560945 | ||
| Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology | Q36846525 | ||
| Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance | Q37066869 | ||
| Lipidomics joins the omics evolution | Q37114718 | ||
| 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production | Q37377292 | ||
| Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells | Q37380645 | ||
| Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies | Q37382152 | ||
| Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. | Q38297724 | ||
| Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. | Q40174892 | ||
| Whole body lipid and energy metabolism in the cancer patient | Q42523948 | ||
| Effect of glucose ingestion on energy substrate utilization during prolonged muscular exercise | Q43615141 | ||
| Plasma nonesterified fatty acid concentration as a risk factor for sudden cardiac death: the Paris Prospective Study | Q43705500 | ||
| Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study | Q43967028 | ||
| Plasma lysophosphatidic acid concentration and ovarian cancer | Q44031447 | ||
| Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study | Q44504050 | ||
| Sphingolipids as bioactive regulators of thrombin generation | Q44727099 | ||
| Lysophospholipids are potential biomarkers of ovarian cancer | Q44973063 | ||
| Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. | Q45919131 | ||
| Influence of a type 2 diabetes associated prostaglandin E synthase 2 polymorphism on blood prostaglandin E2 levels | Q46096818 | ||
| Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. | Q46123291 | ||
| Free fatty acid release from human breast cancer tissue inhibits cytotoxic T-lymphocyte-mediated killing | Q46551712 | ||
| Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. | Q46624327 | ||
| Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention. | Q46835774 | ||
| Use of lysophosphatidic acid in the management of benign and malignant ovarian tumors. | Q46926837 | ||
| Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study | Q48371548 | ||
| Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. | Q50174636 | ||
| Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. | Q51561168 | ||
| The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. | Q51573628 | ||
| Differential mobilization of fatty acids from adipose tissue. | Q51582776 | ||
| Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids | Q56767442 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1812-23 | |
| P577 | publication date | 2011-11-10 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | The human plasma lipidome | |
| P478 | volume | 365 |
| Q64290629 | A Polymer Coating Transfer Enrichment Method for Direct Mass Spectrometry Analysis of Lipids in Biofluid Samples |
| Q64967767 | A Role for Lipid Mediators in Acute Myeloid Leukemia. |
| Q46331253 | A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer. |
| Q91681583 | Accurate mass and retention time library of serum lipids for type 1 diabetes research |
| Q34218428 | Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction |
| Q27014988 | Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs |
| Q57161456 | Alterations in postmenopausal plasmatic lipidome |
| Q28611371 | An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids |
| Q36952174 | An eicosanoid-centric view of atherothrombotic risk factors |
| Q47987183 | Anti-inflammatory activities and glycerophospholipids metabolism in KLA-stimulated RAW 264.7 macrophage cells by diarylheptanoids from the rhizomes of Alpinia officinarum |
| Q54877734 | Assessment of altered lipid homeostasis by HILIC-ion mobility-mass spectrometry-based lipidomics. |
| Q35575141 | Assessment of lipidomic species in hepatocyte lipid droplets from stressed mouse models |
| Q47104991 | Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients. |
| Q36449881 | Biochemical markers of aging for longitudinal studies in humans |
| Q21562282 | Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons |
| Q39102034 | Budding Yeast: An Ideal Backdrop for In vivo Lipid Biochemistry |
| Q51743643 | Cardiometabolic Effects of Anti-obesity Pharmacotherapy. |
| Q35013696 | Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects |
| Q64098178 | Comparison of the microbiome, metabolome, and lipidome of obese and non-obese horses |
| Q36118672 | Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples |
| Q40110465 | Computational Modeling of Competitive Metabolism between ω3- and ω6-Polyunsaturated Fatty Acids in Inflammatory Macrophages |
| Q37110596 | Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes |
| Q60045818 | Cross-Platform Comparison of Untargeted and Targeted Lipidomics Approaches on Aging Mouse Plasma |
| Q34330929 | Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease. |
| Q36528525 | D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile |
| Q45962681 | Deciphering lipid structures based on platform-independent decision rules. |
| Q37251135 | Decreased cord-blood phospholipids in young age-at-onset type 1 diabetes |
| Q34565234 | Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome |
| Q46809101 | Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles |
| Q38027745 | Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases |
| Q26851985 | Eicosanoid storm in infection and inflammation |
| Q37113867 | Evaluation of Collision Cross Section Calibrants for Structural Analysis of Lipids by Traveling Wave Ion Mobility-Mass Spectrometry. |
| Q34155062 | Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays |
| Q30857220 | Evaluation of the photooxidation of galactosyl- and lactosylceramide by electrospray ionization mass spectrometry |
| Q92342099 | Fat for fuel: lipid metabolism in haematopoiesis |
| Q37000534 | Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome |
| Q89126407 | Genetic Regulation of Plasma Lipid Species and Their Association with Metabolic Phenotypes |
| Q90262115 | Genetic architecture of human plasma lipidome and its link to cardiovascular disease |
| Q30301364 | Genetic loci associated with circulating levels of very long-chain saturated fatty acids |
| Q28651511 | Genetic loci associated with circulating phospholipid trans fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium |
| Q57012108 | Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol |
| Q46544317 | Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma. |
| Q47692982 | High Resolution NMR Spectroscopy as a Structural and Analytical Tool for Unsaturated Lipids in Solution |
| Q57417389 | High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis |
| Q37664007 | How Gene Networks Can Uncover Novel CVD Players |
| Q36416679 | Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease |
| Q36560652 | Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach |
| Q37150605 | Immune effector mechanisms implicated in atherosclerosis: from mice to humans |
| Q50095901 | Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD. |
| Q90413453 | Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians |
| Q42052782 | Ion mobility-derived collision cross section as an additional measure for lipid fingerprinting and identification |
| Q63676955 | LIPID MAPS: Serving the next generation of lipid researchers with tools, resources, data, and training |
| Q37421407 | Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease |
| Q37619192 | Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids |
| Q93072725 | Lipid metabolic networks, Mediterranean diet and cardiovascular disease in the PREDIMED trial |
| Q58731392 | Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers |
| Q30249688 | Lipidomic analyses in epidemiology. |
| Q35567919 | Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. |
| Q26825122 | Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections |
| Q37120799 | Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation |
| Q36765489 | Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts |
| Q88228034 | Lipidomics and Biomarker Discovery in Kidney Disease |
| Q58122230 | Lipidomics in Major Depressive Disorder |
| Q38129217 | Lipidomics in longevity and healthy aging |
| Q38081867 | Lipidomics in nutrition and food research. |
| Q37005030 | Lipidomics of familial longevity |
| Q46732985 | Lipidomics: An Evolving Discipline in Molecular Sciences. |
| Q28080734 | Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism |
| Q56395079 | MS-based lipidomics of human blood plasma - a community-initiated position paper to develop accepted guidelines |
| Q90648223 | Maternal obesity leads to long-term altered levels of plasma ceramides in the offspring as revealed by a longitudinal lipidomic study in children |
| Q46252648 | Mechanisms governing the fragmentation of glycerophospholipids containing choline and ethanolamine polar head groups |
| Q36994664 | Metabolic characterization of the natural progression of chronic hepatitis B. |
| Q42372131 | Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge? |
| Q35976648 | Metabolic signatures of insulin resistance in 7,098 young adults |
| Q35152158 | Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts |
| Q64947879 | Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution. |
| Q38903248 | Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry. |
| Q26765005 | Metabolomics in rheumatic diseases: desperately seeking biomarkers |
| Q38280315 | Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice |
| Q33948324 | Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations |
| Q64064177 | Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity |
| Q28088373 | Novel methodologies for biomarker discovery in atherosclerosis |
| Q28390150 | Nutritional lipidomics: molecular metabolism, analytics, and diagnostics |
| Q36112019 | Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions |
| Q60917527 | Online photochemical derivatization enables comprehensive mass spectrometric analysis of unsaturated phospholipid isomers |
| Q47579185 | Patatin-like phospholipases in microbial infections with emerging roles in fatty acid metabolism and immune regulation by Apicomplexa. |
| Q35886279 | Phenotyping drug polypharmacology via eicosanoid profiling of blood. |
| Q36639344 | Phospholipid analysis in sera of horses with allergic dermatitis and in matched healthy controls |
| Q97412613 | Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening |
| Q37163090 | Plasma lipid profiling in a large population-based cohort |
| Q64253357 | Plasma lipidomic profiling in murine mutants of Hermansky-Pudlak syndrome reveals differential changes in pro- and anti-atherosclerotic lipids |
| Q90565536 | Plasma unbound free fatty acid profiles in premature infants before and after intralipid infusion |
| Q34757421 | Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis |
| Q90026306 | Pro- and anti-inflammatory eicosanoids in psoriatic arthritis |
| Q59798181 | Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases Detrimental Inflammation in Aged Mice With Bacterial Meningitis |
| Q47652764 | Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies |
| Q57463954 | Quantitative determination of esterified eicosanoids and related oxygenated metabolites after base hydrolysis |
| Q37399967 | RNA-seq analyses of the midgut from blood- and serum-fed Ixodes ricinus ticks. |
| Q46908112 | Relationship between the lipidome, inflammatory markers and insulin resistance |
| Q56517003 | Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application |
| Q38916357 | Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss. |
| Q60917269 | Serum lipids in adults with late age-related macular degeneration: a case-control study |
| Q55381581 | Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study. |
| Q47783538 | Shared and distinct lipid-lipid interactions in plasma and affected tissues in a diabetic mouse model. |
| Q57034075 | Shotgun Lipidomics Revealed Altered Profiles of Serum Lipids in Systemic Lupus Erythematosus Closely Associated with Disease Activity |
| Q37512573 | Shotgun Lipidomics by Sequential Precursor Ion Fragmentation on a Hybrid Quadrupole Time-of-Flight Mass Spectrometer |
| Q36149181 | Simultaneous Quantification of Serum Nonesterified and Esterified Fatty Acids as Potential Biomarkers to Differentiate Benign Lung Diseases from Lung Cancer |
| Q34599077 | Skeletal muscle insulin resistance associated with cholesterol-induced activation of macrophages is prevented by high density lipoprotein. |
| Q36056872 | Specific Metabolic Markers Are Associated with Future Waist-Gaining Phenotype in Women |
| Q64899850 | Systems Analyses Reveal Physiological Roles and Genetic Regulators of Liver Lipid Species. |
| Q33855179 | Systems-level analysis of innate immunity |
| Q88774089 | Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging |
| Q35070934 | Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids |
| Q56982057 | The influence of citrate, EDTA, and heparin anticoagulants to human plasma LC–MS lipidomic profiling |
| Q33813977 | The personal touch: strategies toward personalized vaccines and predicting immune responses to them |
| Q38071694 | The role of sphingolipids in drug metabolism and transport |
| Q43204925 | Three-dimensional enhanced lipidomics analysis combining UPLC, differential ion mobility spectrometry, and mass spectrometric separation strategies |
| Q48356887 | Unbound free fatty acid profiles in human plasma and the unexpected absence of unbound palmitoleate. |
| Q26775206 | Understanding Metabolomics in Biomedical Research |
| Q58722987 | Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study |
| Q50487358 | Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam. |
Search more.